Drug Shortage Report for PMS-RANITIDINE 300 MG
Report ID | 37318 |
Drug Identification Number | 02242454 |
Brand name | PMS-RANITIDINE 300 MG |
Common or Proper name | RANITIDINE |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-24 |
Estimated end date | 2018-09-10 |
Actual end date | 2018-06-26 |
Shortage status | Resolved |
Updated date | 2018-06-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-06-29 | French | Compare |
v5 | 2018-06-29 | English | Compare |
v4 | 2018-02-15 | French | Compare |
v3 | 2018-02-15 | English | Compare |
v2 | 2018-01-26 | French | Compare |
v1 | 2018-01-26 | English | Compare |
Showing 1 to 6 of 6